Commonality of the IL-4/IL-13 pathway in atopic diseases.
about
Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?New approaches for identifying and testing potential new anti-asthma agents.Dupilumab for the treatment of asthma.Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis.Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis.
P2860
Commonality of the IL-4/IL-13 pathway in atopic diseases.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Commonality of the IL-4/IL-13 pathway in atopic diseases.
@en
Commonality of the IL-4/IL-13 pathway in atopic diseases.
@nl
type
label
Commonality of the IL-4/IL-13 pathway in atopic diseases.
@en
Commonality of the IL-4/IL-13 pathway in atopic diseases.
@nl
prefLabel
Commonality of the IL-4/IL-13 pathway in atopic diseases.
@en
Commonality of the IL-4/IL-13 pathway in atopic diseases.
@nl
P2093
P2860
P1476
Commonality of the IL-4/IL-13 pathway in atopic diseases.
@en
P2093
Gianluca Pirozzi
Namita A Gandhi
Neil M H Graham
P2860
P304
P356
10.1080/1744666X.2017.1298443
P577
2017-03-06T00:00:00Z